BRCA1 Mutational Complementation Induces Synthetic Viability

Joseph Nacson, Daniela Di Marcantonio, Yifan Wang, Andrea J. Bernhardy, Emma Clausen, Xiang Hua, Kathy Q. Cai, Esteban Martinez, Wanjuan Feng, Elsa Callén, Wei Wu, Gaorav P. Gupta, Joseph R. Testa, André Nussenzweig, Stephen M. Sykes, Neil Johnson

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


BRCA1 promotes the DNA end resection and RAD51 loading steps of homologous recombination (HR). Whether these functions can be uncoupled, and whether mutant proteins retaining partial activity can complement one another, is unclear and could affect the severity of BRCA1-associated Fanconi anemia (FA). Here we generated a Brca1CC mouse with a coiled-coil (CC) domain deletion. Brca1CC/CC mice are born at low frequencies, and post-natal mice have FA-like abnormalities, including bone marrow failure. Intercrossing with Brca1Δ11, which is homozygous lethal, generated Brca1CC/Δ11 mice at Mendelian frequencies that were indistinguishable from Brca1+/+ mice. Brca1CC and Brca1Δ11 proteins were individually responsible for counteracting 53BP1-RIF1-Shieldin activity and promoting RAD51 loading, respectively. Thus, Brca1CC and Brca1Δ11 alleles represent separation-of-function mutations that combine to provide a level of HR sufficient for normal development and hematopoiesis. Because BRCA1 activities can be genetically separated, compound heterozygosity for functional complementary mutations may protect individuals from FA.

Original languageEnglish
Pages (from-to)951-959.e6
JournalMolecular cell
Issue number5
StatePublished - Jun 4 2020


Dive into the research topics of 'BRCA1 Mutational Complementation Induces Synthetic Viability'. Together they form a unique fingerprint.

Cite this